The global Microarray Biochip Technology market size is predicted to grow from US$ 1612 million in 2025 to US$ 2693 million in 2031; it is expected to grow at a CAGR of 8.9% from 2025 to 2031.

Microarray or biochip is a lab-oriented microscope slide that is usually made of glass, silicon chip, or nylon membrane. It is a 2D array (sometimes 3D) whose surface is provided with thousands of minute pores in defined positions. The microarray is a recently developed technology and was discovered only two decades ago. It is mostly used in cancer research and in the pharmacological treatment of other diseases like oral lesions. It enables researchers to investigate and analyze the expression of thousands of genes in a single reaction and address various issues.

Key Features

• Global key Microarray Biochip Technology players cover Illumina, Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, PerkinElmer, etc.
• This report provides a detailed analysis in US$ millions of the world Microarray Biochip Technology industry.
• It evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Microarray Biochip Technology.

Segmentation by Type

• DNA Microarray
• Protein Microarray
• Other

Segmentation by Application

• Drug Discovery
• Research
• Diagnostics
• Others

Market by Region

• Americas
• APAC
• Europe
• Middle East & Africa

Company’s Coverage

• Illumina
• Thermo Fisher Scientific
• Agilent Technologies
• Bio-Rad Laboratories
• PerkinElmer
• BioChain
• Sengenics
• Applied Microarrays
• US Biomax

Key Questions Addressed in this Report

• What are the key market trends and drivers?
• What are the emerging pockets of opportunity?
• Who are the leading global companies?